ResearcherEdinburgh Cancer ResearchActive in the last 2 years
Michael F. Olson
Matched on ORCID iD 0000-0003-3428-3507; OpenAlex author ID A5022119524. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 15
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 7
- Radiotherapy drives lung metastasis in PDAC via a RhoGTPase signaling shift towards MRCK-dependency Co-author DOI 10.1101/2025.09.09.673965↗
- Targeting ROCK activity to disrupt and prime pancreatic cancer for chemotherapy. Co-author DOI 10.1080/21541248.2017.1345712↗
- Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth. Last author DOI 10.1158/0008-5472.can-17-1339↗
- ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth. Last author DOI 10.15252/emmm.201606743↗
- Regulation of pancreatic cancer aggressiveness by stromal stiffening. First author DOI 10.1038/nm.4099↗
- ROCK signalling induced gene expression changes in mouse pancreatic ductal adenocarcinoma cells. Last author DOI 10.1038/sdata.2016.101↗
- Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53. Co-author DOI 10.1158/0008-5472.can-10-2267↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nicola Rath · 5 shared papers, 2016–2020 · strength 0.48
- Paper Targeting ROCK activity to disrupt and prime pancreatic cancer for chemotherapy. DOI 10.1080/21541248.2017.1345712↗
- Paper Regulation of pancreatic cancer aggressiveness by stromal stiffening. DOI 10.1038/nm.4099↗
- Paper ROCK signalling induced gene expression changes in mouse pancreatic ductal adenocarcinoma cells. DOI 10.1038/sdata.2016.101↗
- Paul Timpson · 3 shared papers, 2011–2020 · strength 0.24
- Paper Targeting ROCK activity to disrupt and prime pancreatic cancer for chemotherapy. DOI 10.1080/21541248.2017.1345712↗
- Paper Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth. DOI 10.1158/0008-5472.can-17-1339↗
- Paper Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53. DOI 10.1158/0008-5472.can-10-2267↗
- Claire Vennin · 2 shared papers, 2018–2020 · strength 0.21
- Marina Pajic · 2 shared papers, 2018–2020 · strength 0.21
- JP Morton · 1 shared paper, 2025 · strength 0.20
- Joanna L. Birch · 1 shared paper, 2025 · strength 0.20
- Kathy McLay · 1 shared paper, 2025 · strength 0.20
- Mathias Tesson · 1 shared paper, 2025 · strength 0.20
- Kurt I. Anderson · 2 shared papers, 2011–2017 · strength 0.08
- Jennifer P. Morton · 2 shared papers, 2011–2017 · strength 0.08
- Evdokia Michalopoulou · 1 shared paper, 2018 · strength 0.07
- Jurre J. Kamphorst · 1 shared paper, 2018 · strength 0.07
- Andreia V. Pinho · 1 shared paper, 2017 · strength 0.06
- Ilse Rooman · 1 shared paper, 2017 · strength 0.06
- Owen James Sansom · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.